First National Bank of Hutchinson’s Vertex Pharmaceuticals VRTX Stock Holding History

First National Bank of Hutchinson’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,086	Closed	-$970K	–	102
2024 Q3	$970K	Sell	2,086 -273	-12%	-$131K	0.63%	39
2024 Q2	$1.11M	Buy	2,359 +48	+2%	+$20.8K	0.71%	38
2024 Q1	$966K	Buy	2,311 +537	+30%	+$227K	0.65%	38
2023 Q4	$722K	Sell	1,774 -16	-0.9%	-$5.91K	0.52%	51
2023 Q3	$622K	Buy	1,790 +62	+4%	+$21.7K	0.47%	56
2023 Q2	$608K	Buy	1,728 +8	+0.5%	+$2.69K	0.44%	58
2023 Q1	$542K	Buy	1,720 +51	+3%	+$15.3K	0.43%	65
2022 Q4	$482K	Sell	1,669 -4	-0.2%	-$1.22K	0.41%	60
2022 Q3	$484K	Buy	1,673 +111	+7%	+$31.9K	0.39%	52
2022 Q2	$440K	Buy	+1,562	New	+$418K	0.33%	59

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

First National Bank of Hutchinson's VRTX Position: Q4 2024 in Review

First National Bank of Hutchinson sold out of Vertex Pharmaceuticals (VRTX) in Q4 2024, closing a stake of 2,086 shares — an estimated $970K sold.

First National Bank of Hutchinson first reported a position in VRTX in Q2 2022 and held it in 10 quarters. The position peaked at $1.11M in Q2 2024. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q4 2024.

First National Bank of Hutchinson reported no remaining Vertex Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
First National Bank of Hutchinson sold 2,086 Vertex Pharmaceuticals shares in Q4 2024, an estimated $970K.
First National Bank of Hutchinson first reported a position in Vertex Pharmaceuticals in Q2 2022 and held it in 10 quarters.
First National Bank of Hutchinson's Vertex Pharmaceuticals position peaked at $1.11M in Q2 2024.
1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2024.

Based on First National Bank of Hutchinson's 13F filing for Q4 2024, filed 11 Feb 2025.